Home Cart 0 Sign in  
X

[ CAS No. 385-00-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 385-00-2
Chemical Structure| 385-00-2
Chemical Structure| 385-00-2
Structure of 385-00-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 385-00-2 ]

Related Doc. of [ 385-00-2 ]

Alternatived Products of [ 385-00-2 ]

Product Details of [ 385-00-2 ]

CAS No. :385-00-2 MDL No. :MFCD00002411
Formula : C7H4F2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :ONOTYLMNTZNAQZ-UHFFFAOYSA-N
M.W : 158.10 Pubchem ID :9796
Synonyms :

Calculated chemistry of [ 385-00-2 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 33.32
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.14 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.14
Log Po/w (XLOGP3) : 1.59
Log Po/w (WLOGP) : 2.5
Log Po/w (MLOGP) : 2.47
Log Po/w (SILICOS-IT) : 2.06
Consensus Log Po/w : 1.95

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.16
Solubility : 1.09 mg/ml ; 0.00693 mol/l
Class : Soluble
Log S (Ali) : -1.98
Solubility : 1.64 mg/ml ; 0.0104 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.32
Solubility : 0.764 mg/ml ; 0.00483 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.01

Safety of [ 385-00-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 385-00-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 385-00-2 ]
  • Downstream synthetic route of [ 385-00-2 ]

[ 385-00-2 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 385-00-2 ]
  • [ 64248-56-2 ]
Reference: [1] Advanced Synthesis and Catalysis, 2011, vol. 353, # 8, p. 1359 - 1366
[2] Chemical Science, 2018, vol. 9, # 15, p. 3860 - 3865
  • 2
  • [ 67-56-1 ]
  • [ 385-00-2 ]
  • [ 13671-00-6 ]
YieldReaction ConditionsOperation in experiment
82% for 6 h; Reflux General procedure: A catalytic amount of concentrated H2SO4 wasadded to a solution of carboxylic acids 16(a–j) (1.0 mmol)in 50 mL of methanol, and the mixture was refluxed for 6 h. It was allowed to cool. The saturated solution ofNaHCO3 was added to the reaction mixture, and it wasextracted with EtOAc (2 X 50 mL). The combined organiclayer was dried Na2SO4 and concentrated to obtain puremethyl esters 17(a–j).
75.9% Inert atmosphere; Reflux To a suspension of 2,6-difluorobenzoic acid (50 g, 316 mmol) in MeOH (800 mL) was added TsOH ( 6 g, 10percent), the mixture was heated to reflux overnight. The solvent was removed under reduced pressure. The residue was dissolved in EtOAc and washed with saturated NaHCO3 and brinesuccessively. The organic layer was separated, dried over Na2SO and concentrated under reduced pressure to give methyl 2,6-difluorobenzoate. 41 g (75.9percent yield) 1 H NMR (400 MHz, CDCI3) δ ppm 7.37-7.46 (m, 1 H), 6.91 - 6.98 (m, 2H), 3.95 (s, 3H).
73%
Stage #1: for 2 h; Reflux
Stage #2: at 20℃; for 2 h;
Step 2: methyl 2,6-difluorobenzoateTo a solution of 2,6-difluorobenzoic acid (100 g, 0.63 mol) in sulfurous dichloride (150 mL) and the resulting reaction mixture was heated to refluxing for 2 hrs. Sulfurous dichloride was removed in vacuo, the residue in pyridine (100 ml) was added MeOH (100 mL) slowly and stirred at room temperature for 2 hrs. The solvent was removed in vacuo, the residue was dissolved in EtOAc (200 mL) and washed with aqueous NaOH (IN), HC1 (IN) and brine. The solution was dried over Na2S04, filtered and concentrated to afford the desired product (78.8 g, 73percent).1H NMR (CDCI3): ? 7.46-7.38 (1H, m), 6.98-9.93 (2H, m), 3.95 (3H, d, J = 2.0 Hz).
73%
Stage #1: for 2 h; Reflux
Stage #2: for 2 h; Reflux
2,6-difluorobenzoic acid (10 (^, 0.63111001) was dissolved in thionyl chloride (1501 ^), and the resulting mixture was heated under reflux for 2 hours. The excess sodium sulfoxide was distilled off and the resulting residue (100 mL) was added dropwise and the methanol was slowly added dropwise (100 mL). The reaction was stirred at room temperature for 2 hours and the solvent was removed in vacuo to remove the solvent. The resulting oil was dissolved in 200 mL of ethyl acetate and treated with IN sodium hydroxide solution, IN hydrochloric acid , Water and saturated salt water. After evaporation of the solvent in vacuo, the title compound (78.8 g, 73percent) was obtained as an oil.
71% at 20℃; Reflux To a solution of 2,6-difluorobenzoic acid (30.0 g, 190.0 mmol) in MeOH (100 mL) was added concentrated sulfuric acid (5 mL) dropwise at room temperature. The reaction mixture was heated under reflux overnight. The solvent was removed in vacuo. The residue was dissolved in EtOAc and washed with saturated NaHCO3 and brine. The organic layer was dried over anhydrous Na2SO4, filtered and concentrated in vacuo to give 1 (23.2 g, 71percent) as a yellow oil. 1H NMR (CDCl3): δ 7.45–7.39 (m, 1H), 6.98–6.93 (m, 2H), 3.96 (s, 3H).

Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 2, p. 233 - 241
[2] Medicinal Chemistry Research, 2016, vol. 25, # 4, p. 627 - 643
[3] Patent: WO2011/59610, 2011, A1, . Location in patent: Page/Page column 101-102
[4] Patent: WO2013/71865, 2013, A1, . Location in patent: Page/Page column 25
[5] Patent: CN103102349, 2017, B, . Location in patent: Paragraph 0147-0149
[6] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 4, p. 1017 - 1021
  • 3
  • [ 67-56-1 ]
  • [ 385-00-2 ]
  • [ 13671-00-6 ]
  • [ 501433-14-3 ]
Reference: [1] European Journal of Organic Chemistry, 2002, # 19, p. 3351 - 3358
  • 4
  • [ 385-00-2 ]
  • [ 13671-00-6 ]
Reference: [1] Journal of Medicinal Chemistry, 1968, vol. 11, # 4, p. 814 - 819
  • 5
  • [ 18107-18-1 ]
  • [ 385-00-2 ]
  • [ 13671-00-6 ]
Reference: [1] Green Chemistry, 2018, vol. 20, # 17, p. 3931 - 3943
  • 6
  • [ 67-56-1 ]
  • [ 18063-02-0 ]
  • [ 13671-00-6 ]
  • [ 385-00-2 ]
Reference: [1] Journal of Physical Organic Chemistry, 2012, vol. 25, # 3, p. 267 - 270
  • 7
  • [ 348-57-2 ]
  • [ 124-38-9 ]
  • [ 28314-81-0 ]
  • [ 1583-58-0 ]
  • [ 385-00-2 ]
Reference: [1] Journal of Organic Chemistry, 1990, vol. 55, # 2, p. 773 - 775
[2] Journal of Organic Chemistry, 1990, vol. 55, # 2, p. 773 - 775
  • 8
  • [ 385-00-2 ]
  • [ 18063-03-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 1, p. 162 - 166
[2] Russian Journal of Organic Chemistry, 1998, vol. 34, # 2, p. 202 - 204
[3] Journal of Medicinal Chemistry, 1968, vol. 11, # 4, p. 814 - 819
[4] Journal of Agricultural and Food Chemistry, 2010, vol. 58, # 5, p. 3037 - 3042
[5] Letters in Drug Design and Discovery, 2016, vol. 13, # 4, p. 329 - 334
[6] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 10, p. 2544 - 2546
[7] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 14, p. 3263 - 3270
[8] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 16, p. 4127 - 4132
[9] European Journal of Medicinal Chemistry, 2018, vol. 149, p. 170 - 181
  • 9
  • [ 1897-52-5 ]
  • [ 18063-03-1 ]
  • [ 385-00-2 ]
Reference: [1] Tetrahedron Letters, 1995, vol. 36, # 52, p. 9561 - 9564
[2] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 8, p. 1099 - 1104
[3] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 8, p. 1099 - 1104
  • 10
  • [ 385-00-2 ]
  • [ 13697-89-7 ]
Reference: [1] Advanced Synthesis and Catalysis, 2011, vol. 353, # 8, p. 1359 - 1366
[2] Journal of the American Chemical Society, 2017, vol. 139, # 33, p. 11527 - 11536
  • 11
  • [ 385-00-2 ]
  • [ 5509-65-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1968, vol. 11, # 4, p. 814 - 819
  • 12
  • [ 64-17-5 ]
  • [ 385-00-2 ]
  • [ 19064-14-3 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 23, p. 7745 - 7748
  • 13
  • [ 385-00-2 ]
  • [ 19064-14-3 ]
Reference: [1] Journal of Medicinal Chemistry, 1968, vol. 11, # 4, p. 814 - 819
  • 14
  • [ 64-17-5 ]
  • [ 18063-02-0 ]
  • [ 19064-14-3 ]
  • [ 385-00-2 ]
Reference: [1] Journal of Physical Organic Chemistry, 2012, vol. 25, # 3, p. 267 - 270
  • 15
  • [ 385-00-2 ]
  • [ 84832-01-9 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1982, vol. 30, # 10, p. 3530 - 3543
[2] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 4, p. 1017 - 1021
[3] Patent: WO2011/59610, 2011, A1,
[4] Patent: WO2013/71865, 2013, A1,
[5] Patent: CN103102349, 2017, B,
[6] Acta Pharmacologica Sinica, 2017, vol. 38, # 7, p. 1059 - 1068
[7] Patent: CN107722013, 2018, A,
  • 16
  • [ 67-56-1 ]
  • [ 385-00-2 ]
  • [ 84832-01-9 ]
Reference: [1] Journal of Organic Chemistry, 1990, vol. 55, # 7, p. 2034 - 2044
  • 17
  • [ 385-00-2 ]
  • [ 83141-10-0 ]
YieldReaction ConditionsOperation in experiment
71% at 0 - 20℃; for 24 h; Concentrated sulfuric acid (5 mL) was added into 2,6-difluoro benzoic acid (1.4 g, 9 mmol) and potassium nitrate (1 g, 9.9 mmol) was added gradually at 0°C. After the temperature of the reactant was elevated to a room temperature, the reactant was stirred for 24 hours. After pouring ice water into the reaction solution, extracting with ethylacetate, drying with sulfuric anhydride magnesium, and vacuum concentrating, the filtrate solid was washed with diethyl ether, and dried, so that 1.3 g of the target compound, 2,6-difluoro-3-nitro benzoic acid (percentage yield: 71percent), was obtained. 1H NMR(400MHz, DMSO-d6): δ 8.37(td, J = 9.2, 5.6 Hz, 1H), 7.46(t, J = 9.2 Hz, 1H).
Reference: [1] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 11, p. 2647 - 2666
[2] Chemical and Pharmaceutical Bulletin, 1982, vol. 30, # 10, p. 3530 - 3543
[3] Journal of Medicinal Chemistry, 2003, vol. 46, # 10, p. 1905 - 1917
[4] Synlett, 2012, vol. 23, # 7, p. 1039 - 1042
[5] Patent: EP2647637, 2013, A2, . Location in patent: Paragraph 0055
[6] Patent: US4339457, 1982, A,
[7] Bulletin of the Korean Chemical Society, 2016, vol. 37, # 10, p. 1632 - 1637
[8] Acta Pharmacologica Sinica, 2017, vol. 38, # 7, p. 1059 - 1068
[9] Patent: CN107722013, 2018, A, . Location in patent: Paragraph 0071; 0072; 0073; 0074
  • 18
  • [ 385-00-2 ]
  • [ 229178-74-9 ]
YieldReaction ConditionsOperation in experiment
72% at 0℃; for 3.5 h; To a solution of 2,6-difluorobenzoic acid (1.58 g, 10.0 mmol) in concd H2SO4 (25 mL) was added NIS (2.25 g, 10.0 mmol) portion-wise at 0 °C. After being stirred at 0 °C for 3.5 h, the mixture was poured onto crushed ice (10 g), and 3percent Na2SO3 (10 mL) was added. The resulting slurry was stirred at 0 °C for 1 h, filtered, washed by water, dried to give the compound 3 as a white solid (2.05 g, 72percent): 1H NMR (CDCl3) δ 6.78-6.82 (t, 1H, J = 8.4 Hz, ArH), 7.78-7.83 (m, 1H, ArH); GC-MS: 240 [M-44]+.
Reference: [1] Journal of Medicinal Chemistry, 2009, vol. 52, # 15, p. 4869 - 4882
[2] Journal of Agricultural and Food Chemistry, 1999, vol. 47, # 8, p. 3416 - 3424
[3] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 16, p. 5039 - 5045
  • 19
  • [ 124-38-9 ]
  • [ 13697-89-7 ]
  • [ 229178-74-9 ]
  • [ 385-00-2 ]
Reference: [1] Synthesis, 2005, # 4, p. 617 - 621
  • 20
  • [ 385-00-2 ]
  • [ 1103234-56-5 ]
Reference: [1] Patent: WO2013/71865, 2013, A1,
[2] Patent: CN103102349, 2017, B,
[3] Acta Pharmacologica Sinica, 2017, vol. 38, # 7, p. 1059 - 1068
[4] Patent: CN107722013, 2018, A,
  • 21
  • [ 385-00-2 ]
  • [ 6185-28-0 ]
YieldReaction ConditionsOperation in experiment
100% With sodium hydroxide In ethanol; water at 20℃; for 0.166667 h; Sodium 2,6-difluorobenzoate; To a solution of 2,6-difluorobenzoic acid (1.0Og1 6.3mmol) in EtOH and water (5:1 , 6OmL) was added 1 N aqueous sodium hydroxide solution (6.33mL, 6.3mmol). The reaction mixture was stirred for 10 minutes at room temperature and then solvents were removed in vacuo to yield sodium 2,6-difluorobenzoate (1.22g, 6.3mmol, quantitative) as an off white solid. 1H NMR (DMSO) δ 6.89 (2H, m), 7.15 (1 H, m).
Reference: [1] Patent: WO2008/139161, 2008, A1, . Location in patent: Page/Page column 89
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 385-00-2 ]

Fluorinated Building Blocks

Chemical Structure| 6185-28-0

[ 6185-28-0 ]

Sodium 2,6-difluorobenzoate

Similarity: 0.98

Chemical Structure| 1201597-23-0

[ 1201597-23-0 ]

2,6-Difluoro-4-methylbenzoic acid

Similarity: 0.98

Chemical Structure| 1583-65-9

[ 1583-65-9 ]

2-Fluoroisophthalic acid

Similarity: 0.98

Chemical Structure| 367954-99-2

[ 367954-99-2 ]

2,4-Difluoro-5-methylbenzoic acid

Similarity: 0.96

Chemical Structure| 112857-68-8

[ 112857-68-8 ]

2,4-Difluoro-3-methylbenzoic acid

Similarity: 0.96

Aryls

Chemical Structure| 6185-28-0

[ 6185-28-0 ]

Sodium 2,6-difluorobenzoate

Similarity: 0.98

Chemical Structure| 1201597-23-0

[ 1201597-23-0 ]

2,6-Difluoro-4-methylbenzoic acid

Similarity: 0.98

Chemical Structure| 1583-65-9

[ 1583-65-9 ]

2-Fluoroisophthalic acid

Similarity: 0.98

Chemical Structure| 367954-99-2

[ 367954-99-2 ]

2,4-Difluoro-5-methylbenzoic acid

Similarity: 0.96

Chemical Structure| 112857-68-8

[ 112857-68-8 ]

2,4-Difluoro-3-methylbenzoic acid

Similarity: 0.96

Carboxylic Acids

Chemical Structure| 1201597-23-0

[ 1201597-23-0 ]

2,6-Difluoro-4-methylbenzoic acid

Similarity: 0.98

Chemical Structure| 1583-65-9

[ 1583-65-9 ]

2-Fluoroisophthalic acid

Similarity: 0.98

Chemical Structure| 367954-99-2

[ 367954-99-2 ]

2,4-Difluoro-5-methylbenzoic acid

Similarity: 0.96

Chemical Structure| 112857-68-8

[ 112857-68-8 ]

2,4-Difluoro-3-methylbenzoic acid

Similarity: 0.96

Chemical Structure| 2358-29-4

[ 2358-29-4 ]

2,3,6-Trifluorobenzoic acid

Similarity: 0.94